Against backdrop of shelter-in-place, Peninsula biotech asks FDA to approve prostate cancer drug
April 21, 2020 at 17:52 PM EDT
Relugolix is the company's first drug to seek FDA approval.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|